Seres Therapeutics Ownership | Who Owns Seres Therapeutics?
Seres Therapeutics Ownership Summary
Seres Therapeutics is owned by 13.49% institutional investors, 13.00% insiders, and 73.50% retail investors. Fmr is the largest institutional shareholder, holding 14.29% of MCRB shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.57% of its assets in Seres Therapeutics shares.
MCRB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Seres Therapeutics | 13.49% | 13.00% | 73.50% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 21.81M | 14.29% | $18.13M |
| Flagship pioneering | 23.12M | 13.28% | $16.18M |
| Vanguard group | 5.87M | 3.85% | $4.88M |
| Blackrock | 1.76M | 1.21% | $1.28M |
| Blackrock funding, inc. /de | 1.76M | 1.15% | $1.46M |
| Geode capital management | 1.51M | 0.99% | $1.26M |
| Vontobel | 938.29K | 0.61% | $779.72K |
| Charles schwab investment management | 865.83K | 0.57% | $719.50K |
| Northern trust | 721.76K | 0.49% | $522.41K |
| State street | 339.55K | 0.23% | $245.76K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Flagship pioneering | 23.12M | 6.86% | $16.18M |
| Lion point capital, lp | 340.76K | 1.52% | $238.53K |
| Providence wealth advisors | 105.00K | 0.07% | $94.01K |
| Ironwood investment management | 39.59K | 0.02% | $32.90K |
| Bridgeway capital management | 250.00K | 0.00% | $207.75K |
| Aries wealth management | 15.00K | 0.00% | $12.46K |
| Vontobel | 938.29K | 0.00% | $779.72K |
| Cantor fitzgerald, l. p. | 95.74K | 0.00% | $79.56K |
| Arete wealth advisors | 20.90K | 0.00% | $17.00K |
| Engineers gate manager lp | 84.99K | 0.00% | $70.62K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vontobel | 938.29K | 0.00% | 543.47K |
| Ubs group | 342.32K | 0.00% | 307.92K |
| Geode capital management | 1.51M | 0.00% | 121.79K |
| Charles schwab investment management | 865.83K | 0.00% | 117.11K |
| Goldman sachs group | 52.95K | - | 38.28K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 1.76M | - | -5.06M |
| Woodline partners lp | - | - | -2.05M |
| Millennium management | 29.55K | - | -1.78M |
| State street | 339.55K | - | -1.61M |
| Bank of america corp /de/ | 105.04K | - | -1.55M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma investments, lp | 24.41K | - | 24.41K | $20.29K |
| Integrated wealth concepts | 10.00K | 0.00% | 10.00K | $8.31K |
| Macquarie group | 4.95K | - | 4.95K | $3.58K |
Sold Out
| Holder | Change |
|---|---|
| Headlands | -10.00 |
| Point72 (difc) | -17.00 |
| Nelson, van denburg & campbell wealth management group | -20.00 |
| Newedge advisors | -200.00 |
| Huntington national bank | -230.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 3 | -96.00% | 23,487,356 | -62.76% | 13 | 0.79% | - | -100.00% | 1 | -94.44% |
| Dec 31, 2024 | 70 | -13.58% | 62,481,139 | -1.44% | 40 | 2.37% | 25 | -3.85% | 17 | -34.62% |
| Sep 30, 2024 | 81 | -14.74% | 63,396,268 | -8.26% | 41 | 1.86% | 27 | -41.30% | 26 | -3.70% |
| Jun 30, 2024 | 95 | -5.94% | 69,106,531 | -19.34% | 47 | 1.06% | 46 | -2.13% | 27 | -3.57% |
| Mar 31, 2024 | 101 | -9.82% | 85,680,215 | -4.29% | 66 | 1.37% | 47 | 6.82% | 28 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 9.72M | 5.57% | - |
| Fidelity Growth Compy Commingled Pl O | 9.44M | 5.55% | 92.60K |
| Fidelity Growth Company Fund | 6.79M | 3.89% | - |
| Vanguard US Total Market Shares ETF | 4.04M | 2.32% | - |
| Vanguard Total Stock Mkt Idx Inv | 192.82K | 2.21% | - |
| Fidelity Growth Company K6 | 2.37M | 1.36% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 90.73K | 1.04% | 6.76K |
| Fidelity Series Growth Company | 1.68M | 0.96% | 34.40K |
| Vanguard Explorer Inv | 1.22M | 0.72% | - |
| Fidelity Select Biotechnology | 854.35K | 0.50% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Young Teresa L. | See Remarks | Sell | $458.64 |
| May 16, 2025 | Shaff Eric D. | CEO and President | Sell | $1.60K |
| May 15, 2025 | DesRosier Thomas | Chief Legal Officer and EVP | Sell | $575.12 |
| May 16, 2025 | Henn Matthew R | See Remarks | Sell | $560.56 |
| Feb 18, 2025 | Young Teresa L. | See Remarks | Sell | $2.70K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 10 |
| 2024 Q3 | - | 7 |
| 2024 Q2 | - | 6 |
MCRB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools